Uber Technologies yesterday forecast first-quarter bookings short of estimates due to a strong dollar after it reported a profit miss in the October-December period, sending its shares down 7.6 percent at the close in New York.

But the San Francisco-based company also beat fourth-quarter revenue estimates, helped by stable ride-hailing demand for office commutes and a strong holiday season for its delivery services.

Uber's quarterly adjusted EBITDA jumped over 40 percent, but since it did not beat expectations, shares were lower, said Adam Balantyne, senior analyst at Uber shareholder Cambiar Investors.

Already a dominant ride-hailing service in North America, Uber has been trying to convince investors that it has plenty of room to grow by attracting more businesses and self-driving vehicle partners to its platform.

How Tornadoes Impact the Economy

How Tornadoes Impact the Economy

The History of Unions in the United States

The History of Unions in the United States

Centrally Planned Economy: Features, Pros & Cons, and Examples

Centrally Planned Economy: Features, Pros & Cons, and Examples

What Country Spends the Most on Healthcare?

What Country Spends the Most on Healthcare?

SMEs find loans harder to get

SMEs find loans harder to get

Tesla sales decline in California as its reputation drops among US consumers

Tesla sales decline in California as its reputation drops among US consumers

Purchasing manager's index at lowest level in four months

Purchasing manager's index at lowest level in four months

HK banks borrow $1.25 billion from Monetary Authority

HK banks borrow $1.25 billion from Monetary Authority

Kerry races to put Yuen Long flats on the market

Kerry races to put Yuen Long flats on the market

State Pavilia prices flats at 25pc below market rates

State Pavilia prices flats at 25pc below market rates

State Pavilia's second batch priced higher

State Pavilia's second batch priced higher

China's health regulator defends quality of local generic drugs

China's health regulator defends quality of local generic drugs